Trial intelligence / Profile preview

Vitamin D for dyslipidemia in premenopausal women

NCT03133975Phase 3Unknown

Sponsor
Mansoura University
Start
Apr 2017
Primary completion
Dec 2018
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of vitamin d in dyslipidemia, sponsored by Mansoura University. Primary endpoints: Low-Density Lipoprotein at 6 months, High-Density Lipoprotein at 6 months and 1 more. Status: unknown.

02

Drugs

vitamin d
03

Conditions

dyslipidemia

Beyond the preview

Go deeper on NCT03133975.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03133975.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call